Sunresin participated at 2nd China International Vaccine Innovation Summit

Vaccines matter, and the purification process matters for vaccine manufacturing. The 2nd China International Vaccine Innovation Summit (HVIS) took place in Beijing, From 8-9 August.

Vaccine manufacturers, solution providers, investors, as well as policy makers attended this year’s conference with the latest trends, insights, developments and solutions to face the current challenges in vaccine development and innovation.

As a leading technical solution provider in vaccine production, Sunresin participated at the 2nd China International Vaccine Innovation Summit (HVIS) showcasing our latest SEPLIFE® products and solutions in the areas of microcarriers for cell culture and chromatography resins for downstream purification.

Mr. Zheng Pengtao, Vice General Manager of Suzhou Sunresin Biotech Co., Ltd, made a keynote speech at the Summit and presented methods and solutions for the downstream process development of viral biological products by highlighting Sunresin’s best practices supporting vaccine manufacturers in purification.

Mr. Zheng also participated in the Roundtable discussion featuring the pet vaccine market and how local manufacturers could be supported at this crunch time facing both supply chain and technical challenges and how Sunresin’s solutions help to ensure quality and lower cost.  

As a pure player in the separation and purification industry for over 20 years, Sunresin will continue to serve the vaccine sector and the biopharma industry as a whole, in offering a wide range of product specialties and solutions with very attractive delivery times and competitive quality-price ratio.

Sunresin, driving the innovation.